Intel Beats Wall Street Expectations as AI Boom Drives Strongest Sales Growth in 15 Years
Agentic AI drives demand; company raises 2026 capex to $20B and guides higher for Q3.
Already have an account? Sign in.
Agentic AI drives demand; company raises 2026 capex to $20B and guides higher for Q3.
Xos secures its first U.S. Air Force contract to build a military-grade Xos Hub mobile charging system, marking its entry into defense.
Topline data from Amylyx’s Phase 3 LUCIDITY trial of avexitide for PBH arrives August 18. Prior results and unmet need fuel optimism.
4D Molecular gains support as B. Riley views EyePoint’s Phase 3 setback as favorable for its lead gene therapy candidate 4D-150.